CTHRC1: a serum biomarker for a pathological fibroblast in IPF.
Journal articles
- Editorial
Khatri, A; Todd, JL
Published in: Thorax
June 10, 2026
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Thorax
DOI
EISSN
1468-3296
Publication Date
June 10, 2026
Location
England
Related Subject Headings
- Respiratory System
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Khatri, A., & Todd, J. L. (2026). CTHRC1: a serum biomarker for a pathological fibroblast in IPF. Thorax. https://doi.org/10.1136/thorax-2026-225250
Khatri, Aaditya, and Jamie L. Todd. “CTHRC1: a serum biomarker for a pathological fibroblast in IPF.” Thorax, June 10, 2026. https://doi.org/10.1136/thorax-2026-225250.
Khatri A, Todd JL. CTHRC1: a serum biomarker for a pathological fibroblast in IPF. Thorax. 2026 Jun 10;
Khatri, Aaditya, and Jamie L. Todd. “CTHRC1: a serum biomarker for a pathological fibroblast in IPF.” Thorax, June 2026. Pubmed, doi:10.1136/thorax-2026-225250.
Khatri A, Todd JL. CTHRC1: a serum biomarker for a pathological fibroblast in IPF. Thorax. 2026 Jun 10;
Published In
Thorax
DOI
EISSN
1468-3296
Publication Date
June 10, 2026
Location
England
Related Subject Headings
- Respiratory System
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology